Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
Route: BUCCAL; Dosage form: LOZENGE; Potency: NA
Concern score
The concern value is driven by the published classifications and regulatory status below — not by a single signal.
Concern score 45/100 (moderate) · high confidence.
Prevalence of DEXTROSE in our catalog (fda_ndc).
Products
47
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
The published evidence profile currently shaping this ingredient record.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 5 %w/v
US
FDA
Route: INTRASPINAL; Dosage form: INJECTION; Potency: 75 mg
US
FDA
Route: INTRATHECAL; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 1925 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION; Potency: 5 %w/v
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Potency: 51.7 mg
US
FDA
Route: INTRAVENOUS; Dosage form: SOLUTION; Potency: 5.05 %w/v
US
FDA
Route: NASAL; Dosage form: SPRAY, METERED; Potency: 50 mg
US
FDA
Route: ORAL; Dosage form: CONCENTRATE; Potency: 400 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Potency: NA
US
FDA
Route: ORAL; Dosage form: SOLUTION; Potency: 2489 mg/5ml
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 1286 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Potency: 132 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Potency: NA
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Potency: 103.95 mg
US
FDA
Route: SUBLINGUAL; Dosage form: TABLET; Potency: 115.78 mg
US
FDA
FDA NDC lists this ingredient in 47 active drug products and 47 total products.
US
FDA
openFDA substance registry classifies this ingredient as concept.
US
FDA
openFDA substance registry classifies this ingredient as mixture.